IHC of paraffin-embedded Carcinoma of Human prostate tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human lung tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Human pancreas tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Human prostate tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Human endometrium tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human bladder tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Human Kidney tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human liver tissue using anti-NIF3L1 mouse monoclonal antibody.
IHC of paraffin-embedded Carcinoma of Human kidney tissue using anti-NIF3L1 mouse monoclonal antibody.
Anti-NIF3L1 mouse monoclonal antibody immunofluorescent staining of COS7 cells transiently transfected by pCMV6-ENTRY NIF3L1.
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY NIF3L1 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-NIF3L1.
Western blot of extracts (35 ug) from 9 different cell lines by using anti-NIF3L1 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).